Sarath Ranganathan
Overview
Explore the profile of Sarath Ranganathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
2527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morgan R, Du Berry C, OHely M, Gray L, Ranganathan S, Vuillermin P, et al.
Clin Exp Allergy
. 2025 Mar;
PMID: 40070270
No abstract available.
2.
Schneider-Futschik E, Munro C, Quinlan C, Ranganathan S
Pediatr Pulmonol
. 2025 Feb;
60(2):e27505.
PMID: 39935234
Background: People with CF (pwCF) are often treated with prolonged courses of aminoglycosides (AGs), for which known adverse effects include ototoxicity as a subset of hearing impairment (HI). Methods: The...
3.
Liu M, Dumuid D, Olds T, Burgner D, Ellul S, Juonala M, et al.
Child Obes
. 2025 Feb;
PMID: 39932718
We aimed to quantify associations of cardiovascular (CV) large and small artery measures with body composition and body mass (1) separately and (2) in combination in 11- to 12-year-old children...
4.
Du Berry C, Mainzer R, Westrupp N, FitzGerald T, Ranganathan S, Doyle L, et al.
Ann Am Thorac Soc
. 2025 Jan;
PMID: 39835933
The effect of moderate-late preterm (MLP; 32 to 36 completed weeks' gestation) birth on childhood respiratory health is unclear. To assess the effect of being born MLP, compared with being...
5.
Sarkar S, Han J, Azzopardi K, Dhar P, Saeed M, Day S, et al.
BMJ Open Respir Res
. 2025 Jan;
12(1.
PMID: 39832889
Background: The most common cause of death in those with cystic fibrosis (CF) is respiratory failure due to bronchiectasis resulting from repeated cycles of respiratory infection and inflammation. Protease-activated receptor...
6.
Shanthikumar S, Gubbels L, Davies K, Walker H, Wong A, Levi E, et al.
Mucosal Immunol
. 2024 Dec;
PMID: 39675726
Despite the central role of cytokines in mediating inflammation that underlies a range of childhood diseases, cytokine testing remains primarily limited to research settings and surrogate markers of inflammation are...
7.
Saunders T, Burgner D, Ranganathan S
Nat Cardiovasc Res
. 2024 Aug;
1(3):187-188.
PMID: 39195984
No abstract available.
8.
Jacobson J, Fabri L, Osowicki J, Shanthikumar S, Costa A, Ortika B, et al.
PLoS One
. 2024 Jun;
19(6):e0304861.
PMID: 38917227
Pleural empyema is a serious complication of pneumonia in children. Negative bacterial cultures commonly impede optimal antibiotic therapy. To improve bacterial identification, we developed a molecular assay and evaluated its...
9.
Pham H, Vandeleur M, Mainzer R, Ranganathan S
Pediatr Pulmonol
. 2024 Jun;
59(10):2606-2613.
PMID: 38860602
Introduction: Cystic fibrosis transmembrane conductance regulator (CFTR) modulator elexacaftor/tezacaftor/ivacaftor (ETI) significantly improves lung function but its effect on mental health and sleep remains poorly understood. We report on mental health,...
10.